install the new browsing experiences of the basalam application and come to the basalam group. sitting on the front page. oh, the first page of safeh isar is there. look on the other side of the fence, the pleasure of visiting is there. you are sitting stand up in the first row, the first row, the first row, the line of the people, you are the stronghold, your stronghold, this is the table, and there is hope, you are on the other side of the table, your eyes are on you.

in the name of allah, the most merciful, the most merciful, hello, dear compatriots, welcome to the front page program. today , according to the routine of another front page, the servants of the iranian nation will be in front of the camera to talk about policies, strategies and decisions. which has a beneficial effect on the path of one's life , that is also the subject of medicine and treatment. an issue that has a legal position in the world and alhamdulillah the islamic republic of iran has been able to self-sufficiently produce more than 90% of the required drugs internally, an issue that has even now led to exports, and this shows that in this field that the field of modern technology has reached a very high

position, mr. dr. heydari, deputy minister, heydar mohammadi, deputy minister of health, medical education, and also the head of the drug and treatment organization . welcome, mr. dr. mohammad, hello. respected program, i would like to congratulate you on the holy dafa week . i am at your service for all the brave men of this land and water. very big events are being held in iran, we will first see a report about this exhibition, then

we will talk about this issue and its effect on drug production, god willing, we are at your service. an industry with more than 300 types of medicine. 98 to 99. medicine needs are being produced in the country. our drug combos are in last year's number was 40 pens. with the efforts made by individual supply chain agents in different sectors. in fact, 88 less items were reported in the month of shahrivar. even the things that were previously supplied by european companies , fortunately, with the efforts of iranian scientists and specialists, they have all been localized. 225 pharmaceutical factories, 60 tuzi companies and more than 70 raw material production companies are active in the country's pharmaceutical industry in recent years. 62 units and since the beginning of the government, 13 new

pharmaceutical companies have been registered. they brought a product that was produced with nanotechnology . regarding the arrival of pharmaceutical raw materials , which takes a relatively long time, mr. baradaran said: "with new investment in the field of medicine , we will complete the production chains with the cooperation of petrochemicals, the ministry of medicine, and drug manufacturers." only in the area of ​​the chain of completion of the stamenifon from the page that the exporter we are 300 dollars per ton.

which becomes $700 per ton of gasoline , and $30,000 for the final product, which is in the field of syrups and tablets. they will also gain exports. good, radio news. well, doctor, we have seen the report about the iran pharma exhibition. what is the importance of holding such an exhibition in our country and how many domestic and foreign pharmaceutical companies are participating in it ? see our iran exhibition, which is held every year. hold it is one of the biggest

exhibition events that is held in the field of medicine in our country. every year , this event is developing, that is, we have more than 800 companies participating in this exhibition, of which 33 are foreign companies from different countries. most of them are indian and chinese companies and other companies from other countries are present at the exhibition. as you know, more than 99 of our drug markets in 1401 were related to manufactured drugs. that is, thank god. after maybe a few decades of islamic revolution in the field of medicine, we can almost say with pride we have become self-sufficient and there is no drug that we can produce forever. the drugs that are produced inside

the country are of all classes of drug classifications . they are limited to rare drugs that are either produced in small quantities or are of low consumption and justified. it is not economical to produce them, considering that we have a large drug market, naturally , our relationship is strong in the international arena, we can create a good opportunity in these exhibitions so that in a completely competitive environment, all the members of the drug supply chain can communicate with each other, that is, we are here. we have a certificate from the producers of raw materials that the materials the primary production is from different depths , that is, minus one, minus two, minus 3, from various precursors to petrochemicals, as an example of which one of the respected officials announced in the report about saminofen, it has now reached approximately four levels of internal depth, we have two more levels if

we can increase its depth, we can produce it from our own petrochemicals, we don't need to import any more. it is a product that you know is very expensive. well, this is the relationship between the producer of the raw material of the drug and the producer of the final drug, which must get the raw material from the company that produces the drug. to buy in advance it can be held directly without intermediaries, and it can actually have this connection . now, there is a need to discuss the quality of the appropriation of the raw material with the company's formulation. the discussion is that the price will be lower anyway, naturally , the profit will be higher. balter company is going, naturally, the economic justification for developing other lines will increase for them. this exhibition always creates the opportunity in an equal environment for these companies to find each other. our foreign companies

we bring most of the raw materials we need from india and china. well, these companies who have booths here can communicate with the best prices with various qualities. they can exchange information and make their own purchases. iran pharma has signed a contract or a memorandum of understanding between iranian companies and foreign companies for export. naturally , this exhibition arena happens a lot, where iranian companies and foreign companies can be seen as an exhibition place . this is one of the main advantages of this exhibition. that these foreign companies with the company our manufacturers are communicating, the main discussion is mostly about raw materials and preforms. they say that we are the producer of a large part of medicine. usually , the companies that export medicine do not come to iran very much . you have a lot of production. we finally import one percent of our medicines. also, there are certain companies that we buy

from. usually, i mentioned that they are producers of rare or low-use drugs, but most of our drugs are domestically produced, unless the bayan companies are ready to be exported. to buy from iran , be ready to buy medicine from iran. yes, understanding a lot of deals were concluded between iranian and foreign companies, which led to this. in fact, the next relationship for buying, now the buyer or the seller is one of the knowledge that is evolving day by day and the technology is becoming new. is it in the field of technology transfer between us and foreign pharmacists or pharmaceutical manufacturers or vice versa, see what happened in the form of the exhibition or during the year

. see and it leads to the fact that it is a memorandum of understanding. you say when many of our companies in the field of drug production, especially biological drugs, we are the only country in the region that may have entered, we entered first of all in the field of drug production, and we are the largest country in the region that produces many of these drugs. we produced for the first or second time in the region and we are their exporters, so this is attractive for us to transfer technology to neighboring countries in friendly countries , to make the technology available there, to sell it, or to participate , this is possible in the formats various participation in investing, investing from the iranian side or selling technology to foreigners? one of

the important issues in the international system is the use of drug diplomacy. in the past, you also had a trip to china and the city of shanghai to participate in the meeting. in fact , the member countries of shanghai for food and medicine . were there any understandings between you and other members in this regard? yes, the meeting we had on 3 last day, in fact, the meeting of the food and drug organizations of the member countries of the shanghai cooperation organization was held with the aim of developing the access of other countries to actually healthy medicine and their sustainable access. became. the final message of this meeting was that all

the member countries can focus on their strength with a win-win perspective. we should declare our strengths and our added value in the points that all countries should announce their strengths and exchange them in such a way that if we are strong in one area, for example, the biological area that i mentioned, we are at your service. we should provide it to the member countries. if a country, for example, china, is strong in the field of raw materials , it should provide us with the technology of making double materials and other countries based on their capabilities. there are different countries such as uzbekistan, india, which, for example, the united arab emirates was present as an observer country in this meeting , i was present in various other countries, kyrgyzstan, kazakhstan , pakistan.

they are in charge of production in these countries, so they can share the positive and strong contributions of the companies based on which they can have a common point for production in different countries, that is, in china, in iran, in other countries. in this meeting that the report that was presented was well received. the quality of medicines made in iran has sometimes been seen and welcomed even in latin american and african countries such as iraq, afghanistan, etc. considering that the population that is a member of shanghai is something like 3 billion people and it is a major global population.

out of the 7 billion population of the world, what plan do we have to expand our exports because we are a country that almost needs a few small pennies of medicine from outside, and now we have to think of a plan for that harm, see, we are a big city that there is also a large population of china's population of 1.4 billion, a large part of which is actually present in shanghai and beijing. in fact , it was possible in this meeting that we, based on what i said, should provide mutual support for the contributions we have, that is, we should come. to provide the part they need

, we exchanged with even the chinese companies we visited, we got their needs and we announced our needs to them. they both need one we will provide them with a series of our products. certainly, the working group that will be created during this meeting and the information that will be exchanged will lead to the fact that, god willing, an export door and an export window will be opened for the two countries to meet their needs through in fact, they should provide a single window for the world , that is, western countries have human rights and help for human beings. they do not face many countries until now that we have witnessed

we are that even some of the medicines required for special patients are now being prevented from being given to them. what have we done in this regard? have we done this at all in international meetings, which are not few, for example , the group of five of the world health organization has participated in iran . do you convey that they are following such a double standard ? exactly one of the main points of the talks that took place in this meeting was that anyway we have something in common with these countries, with many of these countries and that there are cruel sanctions or restrictions that these countries have in all fields, especially the health field they are affected, despite the fact that they claim that we made an exception in the field of health, in fact , this is not the case with regard to sanctions, even

in the field of health, we expect some drugs related to chemotherapy, some drugs related to thalassemia patients and transplant patients. we are licensed patients , these are not provided to us with difficulty, usually we receive these through international institutions, of course, we do not sit idly by . we have announced in the field covid, within a few months, we produced 6 platforms in the country, i apologize, five platforms in 6 producers, and then it became 7 vaccine producers when we announced that we are going to export. regarding the respiratory ventilators that you said , we needed at the beginning of the corona period. today we export ventilators to european countries, we export anesthesia machines, we export a lot of electroshock devices, expensive devices that we used to get with

difficulty. we are radiation therapy and these things we definitely announce that one of the main points of the meeting we had was to strengthen each other to deal with these cruel sanctions, which we were very successful in this field. we have already conveyed these to the parties participating in this meeting, which, god willing, will definitely be fruitful. medicine is one of the topics that depends on people's lives, so the slightest tension in the market can have wide repercussions. preferably, now we will see a report about it, then we will talk about it

. it has a good market in afghanistan. iranian stoves are popular on the other side of the border due to their low price and high quality. this amount of medicine is very professional and very sensitively inserted, inserted in the transit exit line of amoxil, a very large amount of factor 8 medicine in tajikistan, i went to the hospital, it had all iranian medicines, the medicine goes to afghanistan, is smuggled from afghanistan , is smuggled to tajikistan, the price is 10 times higher wisdom the cheapness of this drug is also the preferred width of the issue that the doctors disagree with. we prefer that width nimai means that we will receive the common width of the country or the width that is freely available, and we will give it to the insurance companies for the difference of the width of 422 .

1401, the government implemented the plan for pharmaceuticals. the goal of the pharmaceutical plan is to get the drug subsidy to the patients, not to the smugglers . it is also through the cheap insurance that the importer is receiving now . the current price shows that the purpose of this plan is to prevent it there were violations and smuggling that was done, leaving the chain, which, alhamdulillah, was realized with the implementation of the plan. according to the report of the anti-trafficking headquarters, with the implementation of the drug plan, the number of drug trafficking discoveries in 14015 has decreased . and allocated medical equipment. the news about which we asked the minister of health. medicines that have very high prices in dollars, and in fact

, the patient does not have the ability to buy them because of the very high prices and the pharmacies are not able to buy them. they charge a very high price , and then, for example, they are threatened that the insurance company wants to pay them after a few months. based on the general health policies and the budget law, the financial resources of the health system should be managed through insurance. hani jalinjad is a news reporter for radio and television. something happened last year, which was absolutely necessary to discuss the preferential width. sometimes, in some manufacturers, some importers compared to the width allocated on time

it is not possible or there may be problems to complain . has this problem been solved or not? you see, the situation of allocating and securing our supply has improved a lot, thanks to god, with the efforts made by the honorable central bank and the representatives of the central bank in other countries . however, as you said, the sanctions are pressured in any way to make the hostile countries effective. one of the routes was the transverse route, which despite all their efforts , their arrow hit the stone. the continuous follow-ups that our experts and our colleagues at the central bank have done, alhamdulillah, different routes for the transfer. finding currency today, almost the conditions of transferring our currency have become very good, god willing, with the continuation of this path, we will not have any problems in this direction. however, in any case, we are on one side of the issue regarding the supply of foreign currency. one side of the issue is the amount of our horizontal resources. the amount

is actually the ability of the central bank to provide the currency transfer width. but in general, alhamdulillah, today our conditions for transferring the width have improved a lot, and this has helped because the condition of our supply of drugs and equipment will improve. what about the working capital of drug companies? because of this, sometimes there is a need to manage it, yes, see when last year, the preferential rate was revised, that is, from the rate of about 420 tomans to the price of about 25,000 tomans , then today it is about 2,850 tomans, the first hall , but on the 25th , it was about 2,500 tomans . the suppliers usually work with a single capital, usually they don't have a fixed capital, they work with the same working capital

, this change that was made was difficult, many companies could not supply the raw materials they needed last year, or sometimes the medicines they needed. they need their equipment now, we still have the equipment in fact, i have a preferred view, but in the field of medicine, we have completely corrected this . it was necessary to follow up and provide the criticism of these with the order given by the honorable first vice president to correct the market regulation and the approvals of the central bank's market regulation headquarters. last year, 15 thousand billion tomans and this year 30 thousand billion tomans, the working capital collections for pharmaceutical companies were approved , alhamdulillah, it helped a lot, that is, our companies were sometimes unable to buy the supply last year, which means that the supply and the central bank were hardly available to them. it was agreed that they could not buy the land because of its liquidity, the change that has been made with this capital investment is that the operating banks are struggling, well , many of the banks are really giving good numbers , some of them are not really cooperating well, which we

usually raised. it was followed up, alhamdulillah, the conditions are good now, according to my information, of the 30 thousand billion that was new, because it was supposed to be the surplus of the fees that were paid to drug companies by the central bank last year, 30 thousand billion, in fact , they will pay more through the operating banks to the companies that i know about 18,19,000 billion have been paid some of them, in fact, the 42 thousand billion that were paid last year should help. anyway , all of them insist that reforming the land policy was a completely correct action, it should have been done, but it should be done now, mr. doctor. do you have a plan to actually remove the preference width or modify these two areas? yes, yes, see. anyway, i said that we should

see the amendment of our compensation policy in accordance with the liquidity of the company and the assets of the central bank. naturally, we requested the central bank of the program and budget organization the insurances actually help us if you feel let's say that the central bank has full cooperation to grant the facilities, the organization of the budget program related to this reform, which must pay to the insurances, that the insurances cover, a certificate in our medicine, we paid attention to the difference between the width of terji and the width of nimai on the insurance organizations. in the way of paying in such a way that the payment did not increase from the people, maybe some cases decreased because more was paid, the same thing should happen for milk and dry food and medical needs. the regulation of the market and related meetings should be brought up and the license issued because you know anyway, this change has a price and should be done with special sensitivity, unlike us, considering that we

had a good and successful experience in this field. yes, will this action be done quickly, and secondly, will the money be paid to the insurance companies, or how did you plan it? see , this year, we requested 15 thousand billion in the budget law for 402 to be funded by the difference, well, in the parliament, 69 thousand billion approved by shadal , we requested again that you have enough credit , if the credit is low, this budget will allocate this credit once a month at the request of the ministry of health. a number is given to the insurance organizations, the insurance organizations give to the hospitals, to the pharmacies, and they actually pay the difference to this chain, so if this credit is low, it does not have the necessary coverage to pay the insurance . what we had for 402 was to correct this 69 thousand billion tomans in the second 6 months, and in the next year, make sure

to set the number to an appropriate amount, because you see, in any case , when you want to reform the land policy, there should be infrastructure in the field of basic goods was implemented when a number of subsidies were given to the people in fact, this same credit was allocated now in our field in the field of health, because we have insurance organizations, it is much easier , we can give exactly that difference. in the field of health, we can tell you exactly how much this or that medical device has changed in price, and that price change will be paid through the insurance organization, so it is necessary to predict the required credit before implementing the plan. we can implement this by the end of the year which, god willing, will have good results for the producers

, especially what is the latest situation of our drug market, because i said that any tension in this market can severely affect people who are naturally very vulnerable due to illness . how is the medicine field? we are waiting for you last year, considering the problems that arose in the supply of currency, in the exchange of currency, in the problems that, anyway, after the covid, the consumption of some of our medicines increased, that early occurrence is actually a problem . if so, we hit a shortage alhamdulillah, ma salal, if i want to compare the situation to your service, to make it more clear , well, last year, we were in these time phases for a while.